CERo Therapeutics Holdings, Inc. (CEROW)
USD 0.01
(-23.73%)
USD 0.01
(-23.73%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -1523.60 | -1.09 Million | -697.1 Thousand |
| Net Income | -2536.23 | -667.73 Thousand | -315.54 Thousand |
| Depreciation & Amortization | - | 1.07 Million | 735.47 Thousand |
| Deferred income taxes | - | - | - |
| Stock-based compensation | - | 381.07 Thousand | 287.73 Thousand |
| Change in working capital | 197.76 | 2.41 Million | -365.07 Thousand |
| Other non-cash items | 814.87 | -2.83 Million | -16.48 Thousand |
| Investing Cash Flow | -7944.74 | 180.83 Million | -178.5 Million |
| Investments in PPE | 4.00 | -694.23 Thousand | -612.56 Thousand |
| Acquisitions | - | - | - |
| Investment purchases | -14.33 Million | -325 Thousand | -178.5 Million |
| Sales/Maturities of investments | 5.63 Million | - | - |
| Other Investing Activities | -7944.74 | 181.16 Million | -306 Thousand |
| Financing Cash Flow | -32.57 Thousand | -138.7 Million | 180.29 Million |
| Debt repayment | -905 Thousand | -650 Thousand | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | -33.48 Thousand | -139.35 Million | - |
| Common Stock Issuance | - | - | 180.29 Million |
| Other Financing Activities | 905.00 | 650.00 | 309.07 Thousand |
| Accounts receivables | - | - | - |
| Accounts payables | - | -68.73 Thousand | 212.17 Thousand |
| Inventory | - | - | - |
| Other working capital | 197.76 | 2.41 Million | -365.07 Thousand |
| Cash at beginning of period | 42.14 Thousand | 1.09 Million | 29.86 Million |
| Cash at end of period | 96.87 | 42.14 Million | 1.09 Million |
| Capital Expenditure | 4.00 | -694.23 Thousand | -612.56 Thousand |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -42.04 Thousand | 41.04 Million | -28.76 Million |
| Free Cash Flow | -1519.60 | -1.78 Million | -1.3 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.44 Million | -2.29 Million | -2.53 Million | -282.76 Thousand | -334.02 Thousand | -2.09 Million |
| Depreciation & Amortization | 293.25 Thousand | 288.16 Thousand | - | - | - | 277.45 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.4 Million | 100.72 Thousand | - | - | - | 27.27 Thousand |
| Change in working capital | 841.4 Thousand | -905.36 Thousand | 1.5 Million | 207.13 Thousand | 199.42 Thousand | -35.5 Thousand |
| Other non-cash items | -3.62 Million | -1.3 Million | -491.57 Thousand | -110.98 Thousand | -121.52 Thousand | 445.85 Thousand |
| Investing Cash Flow | - | - | -7.94 Million | -13.81 Million | 5.68 Million | 285.23 Thousand |
| Investments in PPE | 4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -14.33 Million | -13.89 Million | -68.84 Thousand | - |
| Sales/Maturities of investments | - | - | 5.63 Million | - | 5.07 Million | - |
| Other Investing Activities | - | - | 752.3 Thousand | 73.31 Thousand | 678.98 Thousand | 285.23 Thousand |
| Financing Cash Flow | 2.59 Million | 7.15 Million | -32.57 Million | -27.68 Million | -5.41 Million | 566.51 Thousand |
| Debt repayment | -149.34 Thousand | -388.33 Thousand | -905 Thousand | -160 Thousand | -220 Thousand | -605.23 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -33.48 Million | -27.84 Million | -5.63 Million | - |
| Common Stock Issuance | 2.74 Million | 6.75 Million | - | - | - | - |
| Other Financing Activities | 2.59 Million | 13.73 Thousand | 905.00 | 160 Thousand | 220 Thousand | 525 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -265.01 Thousand | -286.48 Thousand | - | - | - | 209.19 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 841.4 Thousand | -618.87 Thousand | 1.5 Million | 207.13 Thousand | 199.42 Thousand | 108.78 Thousand |
| Cash at beginning of period | 5.55 Million | 96.87 Thousand | 42.14 Million | 119.01 Thousand | 105.23 Thousand | 5.38 Million |
| Cash at end of period | 4.61 Million | 4.59 Million | 96.87 Thousand | 96.87 Thousand | 119.01 Thousand | 3.88 Million |
| Capital Expenditure | 4.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -946.07 Thousand | 4.49 Million | -42.04 Million | -22.14 Thousand | 13.78 Thousand | -1.5 Million |
| Free Cash Flow | -3.53 Million | -5.08 Million | -1.52 Million | -186.6 Thousand | -256.12 Thousand | -2.07 Million |
OMAB
LEGIF
INT
4346
FRW
YOOIF